Sunshine Biopharma, Inc. (SBFM)
1.12
-0.05
(-4.27%)
USD |
NASDAQ |
Sep 03, 16:00
1.12
0.00 (0.00%)
After-Hours: 16:10
Sunshine Biopharma Shareholders Equity (Quarterly) : 27.54M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.54M |
| March 31, 2026 | 21.52M |
| December 31, 2025 | 23.04M |
| September 30, 2025 | 24.20M |
| June 30, 2025 | 25.68M |
| March 31, 2025 | 22.70M |
| December 31, 2024 | 23.50M |
| September 30, 2024 | 25.04M |
| June 30, 2024 | 23.49M |
| March 31, 2024 | 24.82M |
| December 31, 2023 | 21.21M |
| September 30, 2023 | 21.96M |
| June 30, 2023 | 23.11M |
| March 31, 2023 | 19.43M |
| December 31, 2022 | 21.63M |
| September 30, 2022 | 40.38M |
| June 30, 2022 | 41.89M |
| March 31, 2022 | 13.31M |
| December 31, 2021 | 0.2117M |
| September 30, 2021 | -1.174M |
| June 30, 2021 | -0.8727M |
| March 31, 2021 | -1.084M |
| December 31, 2020 | -0.9548M |
| September 30, 2020 | -0.5549M |
| June 30, 2020 | -0.5273M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.7086M |
| December 31, 2019 | -0.7354M |
| September 30, 2019 | -0.7429M |
| June 30, 2019 | -0.8163M |
| March 31, 2019 | -0.2118M |
| December 31, 2018 | -0.0558M |
| September 30, 2018 | 0.0447M |
| June 30, 2018 | -0.2761M |
| March 31, 2018 | -0.5007M |
| December 31, 2017 | -0.5734M |
| September 30, 2017 | -0.3539M |
| June 30, 2017 | -0.6163M |
| March 31, 2017 | -0.261M |
| December 31, 2016 | -0.2097M |
| September 30, 2016 | 0.3226M |
| June 30, 2016 | -0.5484M |
| March 31, 2016 | -0.3554M |
| December 31, 2015 | -0.597M |
| September 30, 2015 | -0.3329M |
| June 30, 2015 | -0.2653M |
| March 31, 2015 | -0.2305M |
| December 31, 2014 | -0.3876M |
| September 30, 2014 | -0.2764M |
| June 30, 2014 | -0.3382M |
| March 31, 2014 | -0.1132M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.63M |
| Total Liabilities (Quarterly) | 6.095M |
| Debt to Equity Ratio | 0.0246 |
| Current Ratio | 5.457 |
| Net Debt Paydown Yield | 1.03% |